 TG Therapeutics Inc NASDAQ: TGTX shares are trading significantly lower Monday morning after the company announced it has voluntarily withdrawn the pending Biologics License Applicationsupplemental New Drug Application for the combination of ublituximab and UKONIQ for the. 